Sign in

CIK 0001357459

  • Non-accelerated filer
  • Smaller reporting company

PALISADE BIO, INC.

Sign in to watch
Ticker
PALI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
522007292
Phone
+1 858-704-4900
Business address
7750 EL CAMINO REAL, SUITE 5200, CARLSBAD, CA, 92009
Former names
PALISADE BIO, INC., Seneca Biopharma, Inc., Neuralstem, Inc.
Open-market buys, last 90 days
$28,800
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$28,800. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Williams Donald Allen +$29K Director 1 filing

Reading 87 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-04-27 Trenschel Robert J. Director Grant or award · Stock Option (Right to Buy) +1,298 1,298
2021-04-27 Trenschel Robert J. Director Grant or award · Stock Option (Right to Buy) +4,406 4,406
2021-04-27 Trenschel Robert J. Director Grant or award · Warrant (right to buy) +40,785 40,785
2021-04-27 Trenschel Robert J. Director Grant or award · Warrant (right to buy) +13,595 13,595
2021-04-27 Trenschel Robert J. Director Grant or award · Warrant (right to buy) +1,223 1,223
2021-04-27 Neal James R Director Grant or award · Stock Option (Right to Buy) +849 849
2021-04-27 Neal James R Director Grant or award · Stock Option (Right to Buy) +3,398 3,398
2021-04-27 Neal James R Director Grant or award · Stock Option (Right to Buy) +1,359 1,359
2021-04-27 Neal James R Director Grant or award · Stock Option (Right to Buy) +5,091 5,091
2021-04-27 Neal James R Director Grant or award · Stock Option (Right to Buy) +1,298 1,298
2021-04-27 Neal James R Director Grant or award · Stock Option (Right to Buy) +4,406 4,406
2021-04-27 Hallam Thomas Chief Executive Officer Grant or award +1,592 1,592
2021-04-27 Hallam Thomas Chief Executive Officer Grant or award · Stock Option (Right to Buy) +4,078 4,078
2021-04-27 Hallam Thomas Chief Executive Officer Grant or award · Stock Option (Right to Buy) +27,189 27,189
2021-04-27 Hallam Thomas Chief Executive Officer Grant or award · Stock Option (Right to Buy) +6,797 6,797
2021-04-27 Hallam Thomas Chief Executive Officer Grant or award · Stock Option (Right to Buy) +477 477
2021-04-27 Hallam Thomas Chief Executive Officer Grant or award · Stock Option (Right to Buy) +2,719 2,719
2021-04-27 Hallam Thomas Chief Executive Officer Grant or award · Stock Option (Right to Buy) +95,572 95,572
2021-04-27 Hallam Thomas Chief Executive Officer Grant or award · Stock Option (Right to Buy) +22,730 22,730
2021-04-27 Hallam Thomas Chief Executive Officer Grant or award · Stock Option (Right to Buy) +8,754 8,754

Page 14 of 21 · 409 trades